A rich pipeline of therapeutic candidates is advancing for Parkinson's disease, many of
which are targeting the underlying pathophysiology of disease. Emerging evidence …

Parkinson's disease (PD) is a prime example of a complex and heterogeneous disorder,
characterized by multifaceted and varied motor-and non-motor symptoms and different …

With a current lack of disease-modifying treatments, an initiative toward implementing a
precision medicine approach for treating Parkinson's disease (PD) has emerged. However …

Introduction: Parkinson's disease (PD) is a severe progressive neurodegenerative disorder.
As yet, no therapeutic agent can prevent the characteristic neuronal cell loss in PD brain …

Parkinson's disease (PD) is the second most common neurodegenerative disorder after
Alzheimer's disease, affecting over 10 million individuals worldwide. While numerous …

Background Much effort has been devoted to the discovery of specific mechanisms between
drugs and single targets to date. However, as biological systems maintain homeostasis at …

Parkinson's disease is a gradually progressive neurodegenerative disorder characterized by
a selective loss of dopaminergic neurons in the midbrain area called the substantia nigra …

PD is a prevalent and progressive neurodegenerative disorder characterized by both motor
and non-motor symptoms. Genes play a significant role in the onset and progression of the …

Understanding the pathophysiology and genetic background of Parkinson's disease (PD)
increases the likelihood of developing effective disease-modifying therapeutic strategies. In …

Parkinson's Disease (PD) is a multifaceted neurodegenerative disorder characterised by
complex molecular dysregulations and diverse comorbidities. It is critical to decode the …